The SARS-CoV-2 as an instrumental trigger of autoimmunity
A Dotan, S Muller, D Kanduc, P David, G Halpert… - Autoimmunity …, 2021 - Elsevier
Autoimmunity may be generated by a variety of factors by creating a hyper-stimulated state
of the immune system. It had been established long ago that viruses are a substantial …
of the immune system. It had been established long ago that viruses are a substantial …
[HTML][HTML] New onset of autoimmune diseases following COVID-19 diagnosis
AE Gracia-Ramos, E Martin-Nares… - Cells, 2021 - mdpi.com
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …
dysregulation of the immune system with the development of autoimmune phenomena. The …
[PDF][PDF] Clinical management of COVID-19: living guideline, 13 January 2023
World Health Organization - 2023 - apps.who.int
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …
Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes
Y Zhang, V Bharathi, T Dokoshi… - Proceedings of the …, 2024 - National Acad Sciences
It is unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
leads to the strong but ineffective inflammatory response that characterizes severe …
leads to the strong but ineffective inflammatory response that characterizes severe …
[HTML][HTML] Musculoskeletal involvement of COVID-19: review of imaging
The global pandemic of coronavirus disease 2019 (COVID-19) has revealed a surprising
number of extra-pulmonary manifestations of severe acute respiratory syndrome coronavirus …
number of extra-pulmonary manifestations of severe acute respiratory syndrome coronavirus …
[HTML][HTML] Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study
M Nurek, C Rayner, A Freyer, S Taylor, L Järte… - British Journal of …, 2021 - bjgp.org
Background In the absence of research into therapies and care pathways for long COVID,
guidance based on 'emerging experience'is needed. Aim To provide a rapid expert guide for …
guidance based on 'emerging experience'is needed. Aim To provide a rapid expert guide for …
[HTML][HTML] Post-COVID-19 arthritis: a case report and literature review
M Gasparotto, V Framba, C Piovella, A Doria… - Clinical …, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen
responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers and …
responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers and …
Molecular mimicry and autoimmunity in the time of COVID-19
M Rojas, M Herrán, C Ramírez-Santana… - Journal of …, 2023 - Elsevier
Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …
(ADs) and represent the most commonly known factor in the development of autoimmunity in …
[HTML][HTML] COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges
Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …
[HTML][HTML] Extra-pulmonary complications in SARS-CoV-2 infection: a comprehensive multi organ-system review
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection, is typically presented with acute symptoms affecting upper and …
2 (SARS-CoV-2) infection, is typically presented with acute symptoms affecting upper and …